Application of HSVtk suicide gene to X-SCID gene therapy: Ganciclovir treatment offsets gene corrected X-SCID B cells
- 10 March 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 341 (2) , 391-398
- https://doi.org/10.1016/j.bbrc.2005.12.199
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisBlood, 2005
- Severe combined immunodeficiency. A model disease for molecular immunology and therapyImmunological Reviews, 2005
- Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemiaBlood, 2004
- Gene Therapy Insertional Mutagenesis InsightsScience, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Characterization of the γc chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID)Human Genetics, 2000
- The Interleukin-2 Receptor γ Chain: Its Role in the Multiple Cytokine Receptor Complexes and T Cell Development in XSCIDAnnual Review of Immunology, 1996
- The Thymidine Kinase/Ganciclovir-Mediated “Suicide” Effect Is Variable in Different Tumor CellsHuman Gene Therapy, 1995
- Inhibition of Melanoma Growth by Adenoviral-Mediated HSV Thymidine Kinase Gene Transfer In VivoJournal of Investigative Dermatology, 1995
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992